BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2002
View Archived Issues
Elan sells remaining stock in Athena Diagnostics
Read More
Better antihyperlipidemic profile reported for metformin plus pioglitazone in type 2 diabetes
Read More
Potential use of pirfenidone in progressive renal disease
Read More
Renoprotective effects of ALT-711 in diabetic rats
Read More
A novel prostate cancer vaccine reported to induce specific immune responses
Read More
New data on the immunomodulatory effects of IL-2 + histamine in advanced melanoma
Read More
Preclinical and preliminary clinical data reported for Pyridorin
Read More
Galapagos Genomics awarded grant for bone disease research
Read More
Morphochem enters research collaboration with AstraZeneca for novel antithrombotics
Read More
Miravant discusses phase III SnET2 data with FDA
Read More
Canadian approval for Thymoglobulin in renal transplant patients
Read More
Expanded indication for EmdogainGel in E.U.
Read More
Acambis completes phase I trial of dengue vaccine component
Read More
Rotigotine CDS reduces symptoms of restless legs syndrome in phase II trial
Read More
PDE4 and/or PDE7 inhibitors identified at Altana Pharma
Read More
New folate analogues for the delivery of therapeutic and diagnostic agents
Read More
Vertex presents novel inhibitors of caspase and TNF-alpha production
Read More
Allergan licenses rights to PEP-005 from Peplin Biotech
Read More
New series of HDAC inhibitors prepared and tested by Roche researchers
Read More
Novel alpha2delta ligands with utility in neuropathic pain and other disorders
Read More
Pharmacia claims new alpha7 nicotinic acetylcholine receptor agonists
Read More
Chemokine CXCR3 antagonists designed by Millennium and Kyowa Hakko
Read More
Phase I IND cleared for LY-674
Read More
SRP-299 enters phase II in childhood atopic dermatitis
Read More
Cotara receives orphan drug status in E.U.
Read More
European Commission grants marketing authorization for Zavesca
Read More
CD22-targeted immunoconjugate characterized at EORTC-NCI-AACR meeting
Read More